<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:hpo ids='HP_0001428'>Somatic mutations</z:hpo> of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> DNA (mtDNA) are common in many human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We have described an oligonucleotide microarray ("MitoChip") for rapid sequencing of the entire <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> genome (Zhou et al, J Mol Diagn 2006), facilitating the analysis of mtDNA mutations in <z:mpath ids='MPATH_481'>preneoplastic lesions</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>We examined 14 precancerous lesions, including seven <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> biopsies, with or without associated <z:mpath ids='MPATH_589'>dysplasia</z:mpath>; four colorectal <z:mpath ids='MPATH_270'>adenomas</z:mpath>; and three inflammatory <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated <z:mpath ids='MPATH_589'>dysplasia</z:mpath> specimens </plain></SENT>
<SENT sid="3" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> cases, matched <z:mpath ids='MPATH_458'>normal</z:mpath> tissues from the corresponding site were obtained as germline control </plain></SENT>
<SENT sid="4" pm="."><plain>MitoChip analysis was performed on DNA obtained from cryostat-embedded specimens </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: A total of 513,639 bases of mtDNA were sequenced in the 14 samples, with 490,224 bases (95.4%) bases assigned by the automated genotyping software </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> <z:mpath ids='MPATH_481'>preneoplastic lesions</z:mpath> examined demonstrated at least one somatic mtDNA sequence alteration </plain></SENT>
<SENT sid="7" pm="."><plain>Of the 100 somatic mtDNA alterations observed in the 14 cases, 27 were non-synonymous coding region mutations (i.e., resulting in an amino acid change), 36 were synonymous, and 37 involved non-coding mtDNA </plain></SENT>
<SENT sid="8" pm="."><plain>Overall, somatic alterations most commonly involved the COI, ND4 and ND5 genes </plain></SENT>
<SENT sid="9" pm="."><plain>Notably, somatic mtDNA alterations were observed in <z:mpath ids='MPATH_481'>preneoplastic lesions</z:mpath> of the gastrointestinal tract even in the absence of histopathologic evidence of <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, suggesting that the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> genome is susceptible at the earliest stages of multistep <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">cancer progression</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: Our findings further substantiate the rationale for exploring the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> genome as a biomarker for the early diagnosis of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, and confirm the utility of a high-throughput array-based platform for this purpose from a clinical applicability standpoint </plain></SENT>
</text></document>